Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Aflibercept in Patients With Retinal Pigment Epithelial Detachment (PED) Secondary to Age Related Macular Degeneration (AMD)

NCT03370380 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.

NCT NCT03370380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03370380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Aflibercept in Patients With Retinal Pigment Epithelial Detachment (PED) Secondary to Age Related Macular Degeneration (AMD)
Lead sponsor
University Hospital Muenster
Phase
Observational
Overall status
Completed
Start date
April 17, 2015
Completion date
April 23, 2018
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pigment epithelial detachment